Literature DB >> 1171762

Immunochemotherapy of human malignant melanoma with chlorambucil-carrying antibody.

T Ghose, S T Norvell, A Guclu, A S Macdonald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171762     DOI: 10.1016/0014-2964(75)90059-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

Review 1.  Combined modality therapy of malignant melanoma.

Authors:  E M Hersh; J U Gutterman; C M McBride
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  Antibodies as specific carriers for chemotherapeutic agents.

Authors:  F H Lee; K M Hwang
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Experimental model of serum therapy for metastasized rabbit transplantable tumors (inhibition of metastatic lesions and life-prolongation).

Authors:  K Nakano; H Tokita; H Amemiya; S Suzuki; K Ohmori; Y Kimura; N Tanaka; T Ueno
Journal:  Jpn J Surg       Date:  1980-06

Review 4.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.

Authors:  T Ghose; S Ferrone; A H Blair; Y Kralovec; M Temponi; M Singh; M Mammen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.

Authors:  J R Johnson; C H Ford; C E Newman; C S Woodhouse; G F Rowland; R G Simmonds
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

7.  Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells.

Authors:  C E Newman; C H Ford; E Parkes
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

Review 8.  Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.

Authors:  Brent A Williams; Arjun Law; Judit Hunyadkurti; Stephanie Desilets; Jeffrey V Leyton; Armand Keating
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.